Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$155,005
-$85,568 QoQ
Shares Held
2,957
-32.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#742
of 1,033 holders
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tradewinds, LLC. holds $12,064,416 across 9 Drug Manufacturers - General names. GSK ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,686 | $9,218,819 | |
| 2 | JNJ |
Johnson & Johnson
|
3,106 | $788,830 | |
| 3 | ABBV |
AbbVie Inc.
|
2,930 | $737,305 | |
| 4 | AMGN |
Amgen Inc
|
1,138 | $412,092 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,016 | $259,056 | |
| 6 | PFE |
Pfizer Inc
|
10,346 | $249,131 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,205 | $184,672 | |
| 8 | GSK |
GSK plc
This page
|
2,957 | $155,005 |
All Filings in GSK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $155,005 | 2,957 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $240,573 | 4,359 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $213,765 | 4,359 | Shares | Sole | 2026-02-13 | |
| 2024-06-30 | $229,960 | 5,973 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $205,392 | 5,666 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $201,936 | 5,666 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $207,289 | 5,826 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $190,037 | 5,408 | Shares | Sole | 2023-02-08 | |
| 2022-06-30 | $283,233 | 6,634 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||